The transcatheter heart valve replacement (TAVR) market is reported to reach a valuation of at USD 8.18 billion in 2025 to USD 32.82 billion by 2035. Demand for TAVR is expected to rise at a CAGR of ...

St. Bernards Medical Center in Arkansas and Missouri successfully performed the first minimally invasive mitral valve repair.

Stony Brook Heart Institute launches new program, offering minimally invasive therapies for symptomatic tricuspid valve ...

The TEER procedure is highly recommended for patients who are considered high surgical risk due to pre-existing issues like ...

In an era of continuous advancements in medical technology, Edwards Lifesciences (NYSE: EW), a global leader in ...

The recent EARLY TAVR trial (Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis) investigated the effect of early intervention with transcatheter aortic ...

Correspondence to Professor Helmut Baumgartner, Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Albert-Schweitzer-Campus 1 ...

This successful TRIC valve implantation demonstrates the hospital’s commitment to cutting-edge cardiac care and underscores ...

YOUR fingernails aren’t just a place to paint nail varnish on – they could provide a window into your health. A subtle but common sign could suggest you have a dangerous form of heart ...

According to a medical report from the Edward Francis Small Teaching Hospital (EFSTH), Musa has been diagnosed with Rheumatic ...

Edwards Lifesciences, a leader in heart medical devices, has shown strong growth, innovation, and attractive valuation. Read more on what makes EW a BUY.

The cardiology team at the MemorialCare Heart & Vascular Institute at Long Beach Medical Center, led by Chief of Cardiology David Shavelle, M.D., performed Long Beach Medical Center's first ...